Turkish Version of the Headache Screening Questionnaire
Validity and Reliability of the Turkish Version of the Headache Screening Questionnaire
1 other identifier
observational
200
0 countries
N/A
Brief Summary
This multi-center, nationwide study aims to evaluate the validity and reliability of the Turkish version of the Headache Screening Questionnaire (HSQ-TR). The 10-item questionnaire is designed to screen for migraine and tension-type headache in individuals with headache complaints. Participants presenting with headache will be enrolled. Each participant will first complete the HSQ-TR and then be examined by a neurologist who will provide a diagnosis according to the ICHD-3 beta criteria. The questionnaire results will be compared with the neurologist's diagnoses to assess criterion validity, including sensitivity, specificity, and agreement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2025
CompletedFirst Posted
Study publicly available on registry
July 2, 2025
CompletedStudy Start
First participant enrolled
July 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedJuly 15, 2025
June 1, 2025
4 months
June 21, 2025
July 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ICHD-3 Beta Classification
Day 1, Two weeks later control
Headache Screening Questionare
Day 1,Two weeks later control
Study Arms (1)
Patients with headache
Interventions
The Headache Screening Questionnaire (HSQ) is a 10-item tool developed to screen for migraine and tension-type headache (TTH), based on the ICHD-3 beta criteria. Each item reflects a diagnostic criterion for migraine or TTH. Participants complete the HSQ and are also evaluated by a neurologist for diagnosis. A score of 6 or higher suggests "probable migraine" or "probable TTH."
Eligibility Criteria
Adult patients (≥18 years old) presenting with headache complaints (migraine or tension-type headache) at outpatient neurology clinics in participating hospitals. Participants must be literate in Turkish and cognitively capable of completing self-report questionnaires. A total of 100 patients will be enrolled across multiple centers in Turkey.
You may qualify if:
- Individuals aged 18 and over who present with headache complaints (migraine or tension-type) and voluntarily agree to participate
You may not qualify if:
- Individuals with severe psychiatric disorders, illiteracy in Turkish, or significant cognitive impairment preventing comprehension of the scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gizem Gürsoy, Medical Doctor
Ümraniye Research and Training Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
June 21, 2025
First Posted
July 2, 2025
Study Start
July 15, 2025
Primary Completion
November 1, 2025
Study Completion
December 15, 2025
Last Updated
July 15, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share